Skip to main content
Caplight Logo









RNATICS

RNATICS

Private
GermanyHealthcare & Life Scienceshttps://rnatics.com/

Last Round

Grant

Feb 20, 2026

Total Funding Raised

$11.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RNATICS is a drug discovery company that develops RNA-based therapeutic methods intended for the treatment of severe diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

RNA therapeuticsantisense oligonucleotideASOmacrophage targetingidiopathic pulmonary fibrosisIPFRNA drug deliverydrug delivery platformmicroRNA inhibitormiRNA inhibitorfibrotic diseaseslung disease treatmentinflammatory diseasesclinical stage biotechbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RNATICS Comparables

Compare RNATICS with similar companies based on industry and business-model similarity.

RNATICS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SpliSense
79%
Novartis
69%
Avalyn Pharma
69%

RNATICS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 20, 2026
AcceleratorJun 26, 2024
GrantJan 13, 2022
SpinoffJan 1, 2021

RNATICS Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 67% MoM, reaching 1.9K.

  • May 15, 2026

    Monthly visitors increased 276% MoM.

RNATICS Filings

Explore SEC and related filing metadata, where available.

RNATICS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RNATICS's valuation, stock price, and market status.

Is RNATICS a public or private company?

RNATICS is a private company.

What is the current stock price of RNATICS?

RNATICS is a private company with no public stock price. No recent secondary market data is available.

How much is RNATICS worth (valuation)?

Valuation information for RNATICS is not publicly available.

Can I buy RNATICS stock?

RNATICS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RNATICS's last funding round?

RNATICS's most recent funding round was Grant on February 20, 2026.

Who are the main investors in RNATICS?

Key investors in RNATICS include Technical University of Munich, Federal Ministry of Research, Technology and Space.

Will RNATICS IPO soon?

No public IPO plans have been announced for RNATICS.

How can I track RNATICS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RNATICS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGermany
Employee Range3
Year Founded2021
Last FundingFeb 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?